Fibrionolytic composition
US5078995A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 11, 1990 |
| Grant date | Jan 7, 1992 |
| Priority date | — |
| Expiry date | May 11, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/49
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In accordance with present invention, a method is provided for reducing tissue damaged by ischemia in animal or human. The method comprises injecting an effective amount of an anticoagulant and a surface-active copolymer into an animal or human with tissue damaged by ischemia tissue. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: EQU HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C.sub.3 H.sub.6 O) has a molecular weight of approximately 950 to 4000, preferably approximately 1200 to 3500, and b is an integer such that the hydrophile portion represented by (C.sub.2 H.sub.4 O) constitutes approximately 50% to 90% by weight of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.